| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome
|
Volkman, Thomas
|
|
2017
|
18 |
C |
p. 103-105
|
artikel
|
| 2 |
Alternative diagnoses in patients referred to specialized centers for suspected MS
|
Yamout, B.I.
|
|
2017
|
18 |
C |
p. 85-89
|
artikel
|
| 3 |
A NMOSD case with multifocal nervous system involvement in a single attack
|
Tanyel, Tuba
|
|
2017
|
18 |
C |
p. 82-84
|
artikel
|
| 4 |
A possible role of impaired cell-mediated immunity in the pathogenesis of tumefactive demyelinating lesions
|
Koudriavtseva, Tatiana
|
|
2017
|
18 |
C |
p. 184-185
|
artikel
|
| 5 |
Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis
|
Shu, Yaqing
|
|
2017
|
18 |
C |
p. 65-70
|
artikel
|
| 6 |
Autoimmune aquaporin-4 induced damage beyond the central nervous system
|
He, Dian
|
|
2017
|
18 |
C |
p. 41-46
|
artikel
|
| 7 |
CD25 gene polymorphism and multiple sclerosis
|
Alsahebfosoul, Fereshteh
|
|
2017
|
18 |
C |
p. 117-118
|
artikel
|
| 8 |
Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies
|
Zhou, Lei
|
|
2017
|
18 |
C |
p. 90-92
|
artikel
|
| 9 |
Cerebral toxoplasmosis in an MS patient receiving Fingolimod
|
Enriquez-Marulanda, Alejandro
|
|
2017
|
18 |
C |
p. 106-108
|
artikel
|
| 10 |
Cognitive impairment in neuromyelitis optica spectrum disorders: What do we know?
|
Eizaguirre, M.B.
|
|
2017
|
18 |
C |
p. 225-229
|
artikel
|
| 11 |
Comparing the efficacy of disease-modifying therapies in multiple sclerosis
|
Mitsikostas, Dimos D.
|
|
2017
|
18 |
C |
p. 109-116
|
artikel
|
| 12 |
Delayed lymphocyte re-population following discontinuation of dimethyl fumarate and after switching to other disease modifying drug therapies
|
Khatri, Bhupendra O.
|
|
2017
|
18 |
C |
p. 60-64
|
artikel
|
| 13 |
Development and validation of the coping with multiple sclerosis questionnaire
|
Dehghani, Ali
|
|
2017
|
18 |
C |
p. 49-55
|
artikel
|
| 14 |
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations
|
Sahraian, Mohammad Ali
|
|
2017
|
18 |
C |
p. 144-151
|
artikel
|
| 15 |
Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study
|
Costers, Lars
|
|
2017
|
18 |
C |
p. 33-40
|
artikel
|
| 16 |
Do gait patterns differ in men and women with multiple sclerosis?
|
Pau, Massimiliano
|
|
2017
|
18 |
C |
p. 202-208
|
artikel
|
| 17 |
Ecotropic Viral Integration Site 5 (EVI5) variants are associated with multiple sclerosis in Iranian population
|
Mazdeh, Mehrdokht
|
|
2017
|
18 |
C |
p. 15-19
|
artikel
|
| 18 |
Editors’ Welcome
|
Waubant, Emmanuelle
|
|
2017
|
18 |
C |
p. A1-A2
|
artikel
|
| 19 |
Effects of cognitive versus motor dual-task on spatiotemporal gait parameters in healthy controls and multiple sclerosis patients with and without fall history
|
Mofateh, Razieh
|
|
2017
|
18 |
C |
p. 8-14
|
artikel
|
| 20 |
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse
|
Miranda Acuña, Jahir
|
|
2017
|
18 |
C |
p. 157-160
|
artikel
|
| 21 |
Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: A descriptive nation-wide study
|
Bizjak, Neli
|
|
2017
|
18 |
C |
p. 56-59
|
artikel
|
| 22 |
Examining the contributions of environmental quality to pediatric multiple sclerosis
|
Lavery, Amy M.
|
|
2017
|
18 |
C |
p. 164-169
|
artikel
|
| 23 |
Fulminant intramedullary spinal cord sarcoidosis
|
Graf, Jonas
|
|
2017
|
18 |
C |
p. 47-48
|
artikel
|
| 24 |
High dose biotin as treatment for progressive multiple sclerosis
|
Birnbaum, Gary
|
|
2017
|
18 |
C |
p. 141-143
|
artikel
|
| 25 |
Information processing deficits as a driving force for memory impairment in MS: A cross-sectional study of memory functions and MRI in early and late stage MS
|
Köhler, Wolfgang
|
|
2017
|
18 |
C |
p. 119-127
|
artikel
|
| 26 |
Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis
|
Oreja-Guevara, Celia
|
|
2017
|
18 |
C |
p. 71-76
|
artikel
|
| 27 |
Interleukin 1 receptor antagonist and 2′-5′-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain
|
AL-Nashmi, Moudi
|
|
2017
|
18 |
C |
p. 1-7
|
artikel
|
| 28 |
Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: A meta-analysis
|
Li, Yu-Feng
|
|
2017
|
18 |
C |
p. 20-25
|
artikel
|
| 29 |
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years
|
Lublin, Fred D.
|
|
2017
|
18 |
C |
p. 95-102
|
artikel
|
| 30 |
Lymphocytes in the treatment with interferon beta-1 b
|
Pavelek, Zbyšek
|
|
2017
|
18 |
C |
p. 29-32
|
artikel
|
| 31 |
Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment
|
Baker, David
|
|
2017
|
18 |
C |
p. 181-183
|
artikel
|
| 32 |
“Nail loss after teriflunomide treatment: A new potential adverse event”
|
Mancinelli, L.
|
|
2017
|
18 |
C |
p. 170-172
|
artikel
|
| 33 |
Neuromyelitis optica spectrum disorders in Iran
|
Eskandarieh, Sharareh
|
|
2017
|
18 |
C |
p. 209-212
|
artikel
|
| 34 |
Optic neuritis with radiological longitudinal spinal cord involvement and seronegative anti-aquaporin antibody: Evidence from a case study
|
Naser Moghadasi, Abdorreza
|
|
2017
|
18 |
C |
p. 26-28
|
artikel
|
| 35 |
Post herpes zoster infection neuromyelitis optica spectrum disorder
|
Mathew, Thomas
|
|
2017
|
18 |
C |
p. 93-94
|
artikel
|
| 36 |
Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
|
Kim, Seungyeon
|
|
2017
|
18 |
C |
p. 77-81
|
artikel
|
| 37 |
Short term outcome of ADEM: Results from a retrospective cohort study from South India
|
Iype, Mary
|
|
2017
|
18 |
C |
p. 128-134
|
artikel
|
| 38 |
The +4259A>C polymorphism of TIM-3 but not -1637C>T polymorphism of TIM-1 is associated with Multiple sclerosis in Isfahan population
|
Pouladian, Masoumeh
|
|
2017
|
18 |
C |
p. 152-156
|
artikel
|
| 39 |
The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada
|
Gerber, Brittany
|
|
2017
|
18 |
C |
p. 218-224
|
artikel
|
| 40 |
The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis
|
Bisgaard, AK
|
|
2017
|
18 |
C |
p. 213-217
|
artikel
|
| 41 |
Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
|
Rouzaud, Claire
|
|
2017
|
18 |
C |
p. 161-163
|
artikel
|
| 42 |
Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions
|
Nathoo, Nabeela
|
|
2017
|
18 |
C |
p. 177-180
|
artikel
|
| 43 |
Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis
|
Eagle, Tessa
|
|
2017
|
18 |
C |
p. 196-201
|
artikel
|
| 44 |
Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia
|
Salcı, Yeliz
|
|
2017
|
18 |
C |
p. 135-140
|
artikel
|
| 45 |
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis
|
Lavorgna, Luigi
|
|
2017
|
18 |
C |
p. 173-176
|
artikel
|
| 46 |
What should a person with relapsing-remitting multiple sclerosis know? – Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0)
|
Heesen, C.
|
|
2017
|
18 |
C |
p. 186-195
|
artikel
|
Tijdschrift beschrijving